Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Paar D et al. |
Life-threatening interaction between clarithromycin and disopyramide. |
1997 |
Lancet |
pmid:9024381
|
Berg-Candolfi M and Candolfi E |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection. |
1996 |
Int. J. Parasitol. |
pmid:9024879
|
Flisch CW et al. |
[A case of arthritis of the wrist caused by Mycobacterium marinum. Review of the literature]. |
1996 |
Ann Chir Main Memb Super |
pmid:9026056
|
Wang XM et al. |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy]. |
1997 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:9028149
|
MacÃas J et al. |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. |
1997 |
AIDS |
pmid:9030376
|
Alarcón T et al. |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9031877
|
Burucoa C et al. |
Western blot monitoring of disseminated Nocardia nova infection treated with clarithromycin, imipenem, and surgical drainage. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9031879
|
Engelhardt E et al. |
[Postoperative infection with Mycobacterium chelonae]. |
1996 |
Hautarzt |
pmid:9036143
|
Yamamoto M et al. |
[The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection]. |
1997 |
Kekkaku |
pmid:9038009
|
Kelleher P et al. |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients. |
1996 |
Genitourin Med |
pmid:9038637
|
Dautzenberg B et al. |
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections. |
1997 Jan-Feb |
Infection |
pmid:9039532
|
Dohil R et al. |
Effective 2-wk therapy for Helicobacter pylori disease in children. |
1997 |
Am. J. Gastroenterol. |
pmid:9040199
|
Lerang F et al. |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? |
1997 |
Am. J. Gastroenterol. |
pmid:9040200
|
Brady RC et al. |
Facial sporotrichoid infection with Mycobacterium marinum. |
1997 |
J. Pediatr. |
pmid:9042142
|
Axon AT et al. |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042977
|
Labenz J et al. |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042978
|
Labenz J et al. |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042979
|
Erah PO et al. |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. |
1997 |
J. Antimicrob. Chemother. |
pmid:9044021
|
Roche B et al. |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. |
1997 |
Rev Rhum Engl Ed |
pmid:9051864
|
Stone GG et al. |
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9056021
|
Moayyedi P et al. |
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. |
1997 |
J. Gastroenterol. |
pmid:9058291
|
GarcÃa-de-Lomas J et al. |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063666
|
Weiss I et al. |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063669
|
Fujii K et al. |
Multiple primary Mycobacterium avium infection of the skin. |
1997 |
Int. J. Dermatol. |
pmid:9071619
|
Labenz J |
[Helicobacter pylori eradication: finally clarity]. |
1996 |
Leber Magen Darm |
pmid:9082109
|
Reed PI and Johnston BJ |
Treatment of Helicobacter pylori infection. |
1997 |
Biomed. Pharmacother. |
pmid:9084725
|
al-Humayyd MS |
Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat. |
1997 Mar-Apr |
Chemotherapy |
pmid:9084915
|
Konishi T and Nakao M |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. |
1997 |
Microbiol. Immunol. |
pmid:9087959
|
Gotoh A et al. |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. |
1997 |
Microbiol. Immunol. |
pmid:9087962
|
Driscoll MS and Tyring SK |
Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. |
1997 |
J. Am. Acad. Dermatol. |
pmid:9091495
|
Gui GP et al. |
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096189
|
Hoogkamp-Korstanje JA et al. |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096192
|
Klapper SR et al. |
Atypical mycobacterial infection of the orbit. |
1995 |
Ophthalmology |
pmid:9097803
|
Matsuoka N et al. |
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. |
1996 |
Clin. Exp. Immunol. |
pmid:9099936
|
DÃaz F et al. |
[Cat-scratch disease. A report of 4 cases and a review of the literature]. |
1997 |
Rev Clin Esp |
pmid:9102668
|
Kato A |
[Effect of erythromycin and clarithromycin on ion transport across dissected canine tracheal epithelium]. |
1997 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9103848
|
Szczebara F et al. |
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9105846
|
Fietta A et al. |
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. |
1997 |
J Chemother |
pmid:9106013
|
Fietta A et al. |
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. |
1997 |
J Chemother |
pmid:9106014
|
Arguedas A et al. |
Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion. |
1997 |
J Chemother |
pmid:9106017
|
Klein JO |
History of macrolide use in pediatrics. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109154
|
McCracken GH |
Microbiologic activity of the newer macrolide antibiotics. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109155
|
Nightingale CH |
Pharmacokinetics and pharmacodynamics of newer macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109156
|
Tarlow MJ |
Macrolides in the management of streptococcal pharyngitis/tonsillitis. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109157
|
Block SL |
Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109158
|
Tarlow MJ et al. |
Future indications for macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109159
|
Rodrigo Sáez L et al. |
[The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin]. |
1997 |
Rev Esp Enferm Dig |
pmid:9115827
|
Cadranel JF et al. |
[Acute symptomatic cytolytic hepatitis probably related to clarithromycin]. |
1996 |
Gastroenterol. Clin. Biol. |
pmid:9119179
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin. |
1997 |
Epidemiol. Infect. |
pmid:9129588
|
|
[Management of atypical Mycobacterium infections in AIDS-patients]. |
1996 |
Internist (Berl) |
pmid:9131082
|
Spicer ST et al. |
The mechanism of cyclosporine toxicity induced by clarithromycin. |
1997 |
Br J Clin Pharmacol |
pmid:9131953
|
Guillemet C et al. |
[Clarithromycin-digoxin: an unrecognized interaction in some patients]. |
1997 |
Presse Med |
pmid:9137381
|
Plemmons RM et al. |
Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. |
1997 |
Clin. Infect. Dis. |
pmid:9142810
|
Khan AA et al. |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145840
|
Collins L and Franzblau SG |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145860
|
Lounis N et al. |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145892
|
Spinzi G et al. |
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9146769
|
Peterson WL |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9146787
|
Chaisson RE et al. |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. |
1997 |
AIDS |
pmid:9147422
|
Rodrigues AD et al. |
Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. |
1997 |
Drug Metab. Dispos. |
pmid:9152603
|
Garrison MW et al. |
Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9154410
|
Misiewicz JJ |
Management of Helicobacter pylori-related disorders. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9160212
|
Peloquin CA and Berning SE |
Advice on treatment of Mycobacterium avium complex infection. |
1997 |
Am J Health Syst Pharm |
pmid:9161632
|
Nilius AM et al. |
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH. |
1997 |
J. Clin. Microbiol. |
pmid:9163435
|
Walsh D et al. |
One week treatment for Helicobacter pylori infection. |
1997 |
Arch. Dis. Child. |
pmid:9166031
|
OÄŸuz O et al. |
Conjunctival involvement in familial chronic benign pemphigus (Hailey-Hailey disease). |
1997 |
Int. J. Dermatol. |
pmid:9169328
|
Alfandari S et al. |
Isolated cutaneous Mycobacterium avium complex infection in AIDS. |
1997 |
Int. J. Dermatol. |
pmid:9169332
|
Tillenburg B et al. |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)]. |
1997 |
Z Gastroenterol |
pmid:9173687
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Veldhuyzen van Zanten SJ et al. |
Helicobacter pylori: new developments and treatments. |
1997 |
CMAJ |
pmid:9176424
|
Nakao K et al. |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. |
1997 |
Am. J. Gastroenterol. |
pmid:9177520
|
Langtry HD and Brogden RN |
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. |
1997 |
Drugs |
pmid:9179528
|
Pellegrin I et al. |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. |
1996 |
J. Antimicrob. Chemother. |
pmid:9182107
|
Kadayifçi A et al. |
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis. |
1997 |
Ann Pharmacother |
pmid:9184727
|
Gisbert JP et al. |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. |
1997 |
Med Clin (Barc) |
pmid:9190436
|
Damianos AJ and McGarrity TJ |
Treatment strategies for Helicobacter pylori infection. |
1997 |
Am Fam Physician |
pmid:9191460
|
Ebell MH et al. |
Evaluation of the dyspeptic patient: a cost-utility study. |
1997 |
J Fam Pract |
pmid:9191627
|
Waites K et al. |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment. |
1997 |
South. Med. J. |
pmid:9191739
|
Katari SR et al. |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. |
1997 |
Clin Transplant |
pmid:9193849
|
Griffith DE |
Nontuberculous mycobacteria. |
1997 |
Curr Opin Pulm Med |
pmid:9193860
|
Villanueva A et al. |
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. |
1997 |
Clin. Infect. Dis. |
pmid:9195073
|
Gabl M et al. |
Flexor tenosynovitis in the hand caused by Mycobacterium malmoense: a case report. |
1997 |
J Hand Surg Am |
pmid:9195437
|
Rubin BK et al. |
Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. |
1997 |
Am. J. Respir. Crit. Care Med. |
pmid:9196110
|
Lo WC et al. |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease. |
1997 |
Zhonghua Yi Xue Za Zhi (Taipei) |
pmid:9198292
|
Fréhel C et al. |
The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin. |
1997 |
Infect. Immun. |
pmid:9199452
|
Marignani M et al. |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. |
1997 |
Scand. J. Gastroenterol. |
pmid:9200297
|
Kato S et al. |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. |
1997 |
Pediatrics |
pmid:9200377
|
Götz JM et al. |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. |
1997 |
Gut |
pmid:9203935
|
Verhaegen J et al. |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae. |
1997 |
Acta Clin Belg |
pmid:9204588
|
Kim MJ et al. |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment. |
1997 |
Gastroenterology |
pmid:9207259
|
Mikasa K et al. |
Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. |
1997 Jul-Aug |
Chemotherapy |
pmid:9209786
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Chimura T |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. |
1997 |
Jpn J Antibiot |
pmid:9212369
|
Lim AG et al. |
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218079
|
Best LM et al. |
Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218854
|
O'Brien B et al. |
Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218858
|
Hoppe JE and Tschirner T |
Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9218920
|